EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Evaxion A/S
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$3.33+0.50 (+17.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Evaxion A/S from other investors
No posts about EVAX yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.